Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Burcelin

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Journees Annuelles De Diabetologie De L'Hotel-Dieu|July 19, 2003
[Apollinaire Bouchardat prize 2003. Glycemic equilibrium and glucose detection]R Burcelin
Diabetes & Metabolism|January 8, 2011
The gut-brain axis: a major glucoregulatory playerR Burcelin
Diabetes & Metabolism|November 26, 2008
What is known, new and controversial about GLP-1? Minutes of the 1st European GLP-1 Club Meeting, Marseille, 28-29 May 2008R Burcelin,
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1992
[Regulation of cellular transport of glucose and its perturbations in diabetes]R Burcelin, J Girard
Diabetes & Metabolism|November 16, 2010
GLP-1: what is known, new and controversial in 2010?R Burcelin, S Dejager
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|September 17, 2016
Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesityR Burcelin, P Gourdy
Diabetes & Metabolism|March 26, 2013
Incretins: what is known, new and controversial in 2013?R Burcelin, B Thorens,
Diabetes|May 26, 2001
Evidence that extrapancreatic GLUT2-dependent glucose sensors control glucagon secretionR Burcelin, B Thorens
Diabetes|October 4, 2000
Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilizationR Burcelin, W Dolci, B Thorens
Metabolism: Clinical and Experimental|February 19, 1999
Long-lasting antidiabetic effect of a dipeptidyl peptidase IV-resistant analog of glucagon-like peptide-1R Burcelin, W Dolci, B Thorens
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Journees Annuelles De Diabetologie De L'Hotel-Dieu|July 19, 2003
[Apollinaire Bouchardat prize 2003. Glycemic equilibrium and glucose detection]R Burcelin
Diabetes & Metabolism|January 8, 2011
The gut-brain axis: a major glucoregulatory playerR Burcelin
Diabetes & Metabolism|November 26, 2008
What is known, new and controversial about GLP-1? Minutes of the 1st European GLP-1 Club Meeting, Marseille, 28-29 May 2008R Burcelin,
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1992
[Regulation of cellular transport of glucose and its perturbations in diabetes]R Burcelin, J Girard
Diabetes & Metabolism|November 16, 2010
GLP-1: what is known, new and controversial in 2010?R Burcelin, S Dejager
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|September 17, 2016
Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesityR Burcelin, P Gourdy
Diabetes & Metabolism|March 26, 2013
Incretins: what is known, new and controversial in 2013?R Burcelin, B Thorens,
Diabetes|May 26, 2001
Evidence that extrapancreatic GLUT2-dependent glucose sensors control glucagon secretionR Burcelin, B Thorens
Diabetes|October 4, 2000
Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilizationR Burcelin, W Dolci, B Thorens
Metabolism: Clinical and Experimental|February 19, 1999
Long-lasting antidiabetic effect of a dipeptidyl peptidase IV-resistant analog of glucagon-like peptide-1R Burcelin, W Dolci, B Thorens
Pageof 7